EVIDENCE CLAIM
A prescribing cascade can occur when an adverse drug effect is misread as a new condition and treated with another medication; one documented calcium-channel-blocker/diuretic cascade in older adults has been associated with higher rates of serious adverse events.
- Evidence category
- Strong human evidence
- Claim type
- Empirical
- Last reviewed
- September 15, 2026
This page isolates one claim from the wider argument of The Human OS Manual.
The classification describes the evidence supporting this claim, not the Human OS framework as a whole.
What the evidence supports
Savage and colleagues documented higher subsequent loop-diuretic dispensing after calcium-channel-blocker initiation in older adults with hypertension, consistent with a recognized prescribing cascade. Rochon and colleagues then studied this specific cascade in 39,347 older adults and found a higher rate of emergency-room visits or hospitalizations in the cascade group over 90 days (HR 1.21, 95% CI 1.02–1.43).
What it does not establish
These studies concern a specific calcium-channel-blocker/diuretic cascade in older adults. They do not imply that medication combinations are generally inappropriate, that every new symptom after medication is an adverse effect, or that medication should be changed without clinical review.
Context
Chapter 31 uses prescribing cascades as an example of how a locally reasonable intervention can create additional burden when the wider sequence is missed.
Evidence classification
Strong human evidence
Supported by appropriate human studies, major reviews, trials, cohort research, or converging evidence. The strength of the category does not remove population, dose, timing, or context limitations.
Sources
Sources are listed according to the role they play in this claim. One source may provide direct support, another may explain a mechanism, establish a limitation, or prevent an interpretation from becoming broader than the evidence allows.
Primary support
Rachel D. Savage et al., “Evaluation of a Common Prescribing Cascade of Calcium Channel Blockers and Diuretics in Older Adults With Hypertension,” JAMA Internal Medicine 180, no. 5 (2020): 643–651, https://doi.org/10.1001/jamainternmed.2019.7087.
journal article · longitudinal cohort
Population-based evidence documenting the calcium-channel-blocker/diuretic prescribing cascade in older adults.
Supporting evidence
Paula A. Rochon et al., “Association of a Calcium Channel Blocker and Diuretic Prescribing Cascade with Adverse Events: A Population-Based Cohort Study,” Journal of the American Geriatrics Society 72, no. 2 (2024): 467–478, https://doi.org/10.1111/jgs.18683.
journal article · longitudinal cohort
Population-based cohort evidence associating the specific cascade with a higher rate of serious adverse events.
Where this appears in the book
The printed book preserves the claim inside the argument that gives it meaning. These references connect the current digital record to the first-edition evidence trail.
Chapter 31: Designing a Life That Ages Well
Prescribing cascades in older adults. · First edition, 2026
Human OS connections
This claim connects to the following parts of the Human OS architecture. The module labels locate the claim inside the framework; they do not imply that the research source validates the architecture itself.
Read the argument in context
The Evidence Map separates one claim from the wider architecture. The Human OS Manual connects the evidence across biology, behavior, environment, recovery, adaptation, relationships, and time.